Child Clinical Trial - The Effect of a Zero Tolerance Program (SToP) on

Status Recruiting

Clinical Trial Summary

Although the ban on indoor smoking has greatly reduced secondhand smoke (SHS) exposure in public spaces, the home environment is still the primary source of exposure to SHS, particularly in children under the age of five. Although attempts are often made to prevent or reduce children's exposure to SHS, such as education, counseling, and exposure feedback to parents, exposure remains. Although using materials such as brochures, messages, posters and reminders that will minimize the harms such as protecting children from SHS will reduce the exposure, exposure continues in the long term.The aim of this study is to compare the effect of giving exposure feedback to the parents according to the zero tolerance program (SToP) on the urinary cotinine level of the children. In this study with active control group, single-blind (participant), randomized control, stratified block randomization (1:1) will be performed. Totally 58 participants including STOP intervention group (n:29) and the exposure feedback group (n:29), which is the active control group, were planned to be included in the study, which was planned to be conducted between January and September 2023. Cotinine-sensitive dipstick test kits will be used for the primary outcome (urine cotinine). Cotinine-sensitive dipstick test kit is a simple, cost-effective test to determine smoking status. It is an easy-to-read test strip that can be used with either a saliva or a urine sample. Secondary outcomes will be evaluated by information form on exposure to second-hand smoke, an attitude form on exposure to second-hand smoke, and a scale of beliefs towards third-hand smoke. This protocol will demonstrate whether SToP interventions, a sustainable program for children at high risk of secondhand tobacco exposure, are a viable intervention for parents on how to reduce exposure.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Child
Exposure to Environmental Pollution
Parents
Second Hand Smoke
Urine

Clinical Trial Details

NCT number	NCT05545748
Study type	Interventional
Source	Akdeniz University
Contact	Sebahat Gözüm, Professor
Phone	+905332841250
Email	sgozum@akdeniz.edu.tr
Status	Recruiting
Phase	N/A
Start date	July 17, 2023
Completion date	May 2, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06320626` - Pharmacokinetic-guided Dosing of Emicizumab	Phase 4
Completed	`NCT04011852` - The Role of Chest Electrical Impedance Tomography in the Pediatric Ventilator Weaning
Completed	`NCT03497663` - VIA Family - Family Based Early Intervention Versus Treatment as Usual	N/A
Recruiting	`NCT05016271` - Health Benefits of Air Purifiers in Primary School Students	N/A
Completed	`NCT02551978` - Kids Obesity Prevention Program - Study (KOP)	N/A
Completed	`NCT02240368` - Performance Evaluation of the Depth of Anesthesia Monitors in Pediatric Surgery
Completed	`NCT03946137` - Chest Therapy and Postural Education in Children With Cerebral Palsy	N/A
Completed	`NCT01918020` - Impact Study of Minnesota SNAP-Ed Health and Nutrition Education Programs	N/A
Completed	`NCT01267097` - The PAC Study: Parents as Agents of Change in Pediatric Weight Management	N/A
Recruiting	`NCT04022460` - Using Personal Mobile Technology to Identify Obstructive Sleep Apnea in Children With Down Syndrome (UPLOAD)
Completed	`NCT05538039` - Reducing Anxiety of Children and Their Parents in the Pre-elective Surgery Process	N/A
Completed	`NCT03156465` - Iowa Cochlear Implant Clinical Research Center Hybrid L24 and Standard Cochlear Implants in Profoundly Deaf Infants	N/A
Not yet recruiting	`NCT05914324` - Outpatient Pediatric Pulse Oximeters in Africa	N/A
Not yet recruiting	`NCT04827108` - Psychometric Properties of the Chinese Version of PeNAT
Recruiting	`NCT04888195` - Symptom Clusters in Hong Kong Chinese Children With Blood Cancer
Completed	`NCT05374902` - Efficacy of Animation, Buzzy, and Multiple Interventions on Pain in Children	N/A
Not yet recruiting	`NCT04853303` - VR to Improve CINV, Sleep and Pain Among Children With Cancer in HK	N/A
Completed	`NCT04665453` - Dexmedetomidine and Melatonin for Sleep Induction for EEG in Children	N/A
Completed	`NCT04082247` - Healthy Children 2021 Study in Childcare Centers	N/A
Completed	`NCT02858531` - Predictive Tracking of Patient Flow in the Emergency Services During the Virus Winter Epidemics

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Effect of a Zero Tolerance Program (SToP) on Child's Urine Cotinine Level According to Exposure Feedback — SToP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms